Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice

• Hoofdauteurs: Geng-Ruei Chang (Auteur), Po-Hsun Hou (Auteur), Wei-Cheng Yang (Auteur), Chao-Min Wang (Auteur), Pei-Shan Fan (Auteur), Huei-Jyuan Liao (Auteur), To-Pang Chen (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2021-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Doxepin is commonly prescribed for depression and anxiety treatment. Doxepin-related disruptions to metabolism and renal/hepatic adverse effects remain unclear; thus, the underlying mechanism of action warrants further research. Here, we investigated how doxepin affects lipid change, glucose homeost...